Oragenics Inc (OGEN)
0.274
0.00 (0.00%)
USD |
NYAM |
Nov 22, 16:00
0.2809
+0.01
(+2.52%)
Pre-Market: 20:00
Oragenics Free Cash Flow: -7.682M for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2024 | -7.682M |
| June 30, 2024 | -7.214M |
| March 31, 2024 | -8.246M |
| December 31, 2023 | -7.291M |
| September 30, 2023 | -8.621M |
| June 30, 2023 | -10.89M |
| March 31, 2023 | -11.70M |
| December 31, 2022 | -15.36M |
| September 30, 2022 | -15.42M |
| June 30, 2022 | -16.22M |
| March 31, 2022 | -14.91M |
| December 31, 2021 | -13.51M |
| September 30, 2021 | -14.64M |
| June 30, 2021 | -14.70M |
| March 31, 2021 | -17.46M |
| December 31, 2020 | -16.95M |
| September 30, 2020 | -17.27M |
| June 30, 2020 | -15.98M |
| March 31, 2020 | -14.65M |
| December 31, 2019 | -13.04M |
| September 30, 2019 | -12.13M |
| June 30, 2019 | -11.27M |
| March 31, 2019 | -10.05M |
| December 31, 2018 | -9.204M |
| September 30, 2018 | -7.521M |
| Date | Value |
|---|---|
| June 30, 2018 | -6.346M |
| March 31, 2018 | -5.83M |
| December 31, 2017 | -6.364M |
| September 30, 2017 | -6.969M |
| June 30, 2017 | -7.228M |
| March 31, 2017 | -7.383M |
| December 31, 2016 | -7.102M |
| September 30, 2016 | -6.800M |
| June 30, 2016 | -6.506M |
| March 31, 2016 | -5.551M |
| December 31, 2015 | -5.292M |
| September 30, 2015 | -4.902M |
| June 30, 2015 | -4.696M |
| March 31, 2015 | -5.427M |
| December 31, 2014 | -5.670M |
| September 30, 2014 | -5.619M |
| June 30, 2014 | -6.495M |
| March 31, 2014 | -6.806M |
| December 31, 2013 | -6.783M |
| September 30, 2013 | -7.304M |
| June 30, 2013 | -6.506M |
| March 31, 2013 | -5.650M |
| December 31, 2012 | -5.212M |
| September 30, 2012 | -4.862M |
| June 30, 2012 | -5.203M |
Free Cash Flow Range, Past 5 Years
-17.46M
Minimum
Mar 2021
-7.214M
Maximum
Jun 2024
-13.09M
Average
-14.65M
Median
Free Cash Flow Benchmarks
| Shuttle Pharmaceuticals Holdings Inc | -5.699M |
| Alaunos Therapeutics Inc | -11.76M |
| SELLAS Life Sciences Group Inc | -33.07M |
| Galectin Therapeutics Inc | -33.68M |
| Anavex Life Sciences Corp | -30.00M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -1.970M |
| Cash from Financing (Quarterly) | 3.766M |
| Free Cash Flow Per Share (Quarterly) | -0.3018 |
| Free Cash Flow Yield | -654.1% |